Gef-h1b: Biomarkers, Complexes, Assays And Therapeutic Uses Thereof


The present invention relates to diagnosing abnormal cell proliferation in biological samples and screening for drugs which inhibit, reduce or abolish cell growth, especially tumorigenic cell growth, by detecting a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S.

Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 18, 2011
  • Application: Sep 11, 2008
    US US 23213408 A
  • Priority: Sep 11, 2008
    US US 23213408 A
  • Priority: Jul 2, 2003
    US US 61167103 A
  • Priority: Apr 4, 2003
    US US 46005303 P
  • Priority: Jul 5, 2002
    US US 39360002 P

Download Citation

Sign in to the Lens